BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang Z, Wu Q, Wang Q. Effect of celecoxib on improving depression: A systematic review and meta-analysis. World J Clin Cases 2022; 10(22): 7872-7882 [PMID: 36158469 DOI: 10.12998/wjcc.v10.i22.7872]
URL: https://www.wjgnet.com/2307-8960/full/v10/i22/7872.htm
Number Citing Articles
1
Marianela Evelyn Traetta, Adriano Maia Chaves Filho, Elizabeth Toyin Akinluyi, Marie-Ève Tremblay. MicrogliaAdvances in Neurobiology 2024; 37: 457 doi: 10.1007/978-3-031-55529-9_26
2
Rui Sun, Meng-Yu Tang, Dan Yang, Yan-Yi Zhang, Yi-Heng Xu, Yong Qiao, Bin Yu, Shu-Xia Cao, Hao Wang, Hui-Qian Huang, Hong Zhang, Xiao-Ming Li, Hong Lian. C3aR in the medial prefrontal cortex modulates the susceptibility to LPS-induced depressive-like behaviors through glutamatergic neuronal excitabilityProgress in Neurobiology 2024; 236: 102614 doi: 10.1016/j.pneurobio.2024.102614
3
Monika Dominiak, Adam Gędek, Michalina Sikorska, Paweł Mierzejewski, Marcin Wojnar, Anna Z. Antosik-Wójcińska. Acetylsalicylic Acid and Mood Disorders: A Systematic ReviewPharmaceuticals 2022; 16(1): 67 doi: 10.3390/ph16010067
4
Yishu Yin, Ting Ju, Deyong Zeng, Fangyuan Duan, Yuanbing Zhu, Junlian Liu, Yongzhi Li, Weihong Lu. “Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depressionPharmacological Research 2024; 207: 107322 doi: 10.1016/j.phrs.2024.107322
5
Urszula Bąk, Anna Krupa. Challenges and Opportunities for Celecoxib RepurposingPharmaceutical Research 2023; 40(10): 2329 doi: 10.1007/s11095-023-03571-4
6
Yu-qi Chen, Jun-rui Ye, Sha-sha Wang, Ye Peng, Run Zhou, Ruo-lan Yuan, Wen-fei Wang, Shi-feng Chu, Zhao Zhang, Nai-hong Chen. Esflurbiprofen exerts a fast-onset antidepressant effect by blocking SERT-nNOS interactionActa Pharmacologica Sinica 2025;  doi: 10.1038/s41401-025-01666-9
7
Mario Pinzi, Andrea Fagiolini, Despoina Koukouna, Giacomo Gualtieri, Maria Beatrice Rescalli, Caterina Pierini, Simone Pardossi, Benjamin Patrizio, Alessandro Cuomo. Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical TranslationCells 2025; 14(19): 1558 doi: 10.3390/cells14191558
8
Adam Gędek, Zofia Szular, Anna Z. Antosik, Paweł Mierzejewski, Monika Dominiak. Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsJournal of Clinical Medicine 2023; 12(10): 3497 doi: 10.3390/jcm12103497
9
Ana Salomé Correia, Nuno Vale. Advancements Exploring Major Depressive Disorder: Insights on Oxidative Stress, Serotonin Metabolism, BDNF, HPA Axis Dysfunction, and Pharmacotherapy AdvancesInternational Journal of Translational Medicine 2024; 4(1): 176 doi: 10.3390/ijtm4010010
10
Mohammad M Khan, Zaw Ali Khan, Mohsin Ali Khan. Metabolic complications of psychotropic medications in psychiatric disorders: Emerging role of <i>de novo</i> lipogenesis and therapeutic considerationWorld Journal of Psychiatry 2024; 14(6): 767-783 doi: 10.5498/wjp.v14.i6.767
11
Xiao Feng, Min Jia, Meng Cai, Tong Zhu, Kenji Hashimoto, Jian-Jun Yang. Central-peripheral neuroimmune dynamics in psychological stress and depression: insights from current researchMolecular Psychiatry 2025; 30(10): 4881 doi: 10.1038/s41380-025-03085-y
12
Mohammad M Khan, Zaw Ali Khan, Mohsin Ali Khan, Gauri Pandey. Childhood insulin resistance and neural stem cell dysfunction in psychiatric disorders: Role of <i>de novo</i> lipogenesis and treatment perspectivesWorld Journal of Stem Cells 2025; 17(7): 106194 doi: 10.4252/wjsc.v17.i7.106194
13
Sahar Ansari, Hossein Sanjari Moghaddam, Fatemeh A. Basti, Mohammadreza Salehi, Shahin Akhondzadeh. Efficacy and safety of celecoxib monotherapy for treatment of moderate depressive symptoms following COVID-19 infection: A randomized, double-blind, placebo-controlled trialJournal of Psychosomatic Research 2023; 174: 111471 doi: 10.1016/j.jpsychores.2023.111471
14
Sergey K. Zyryanov, Elena A. Baybulatova. Current challenges for therapy of comorbid patients: a new look at celecoxib. A reviewTerapevticheskii arkhiv 2024; 96(5): 531 doi: 10.26442/00403660.2024.05.202769
15
Daniel Kinderlehrer. Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and NeuroplasticityNeuropsychiatric Disease and Treatment 2025; : 141 doi: 10.2147/NDT.S500337
16
Kriti Sharma, Devendra Kumar, Nisha Chandna, Jitander K. Kapoor. Celecoxib Reimagined: Multifunctional Roles in Advanced Drug Delivery and TherapeuticsChemistrySelect 2025; 10(31) doi: 10.1002/slct.202502652
17
A Halaris, A Sayed, M Hakimi, J Sinacore. Modulation of the inflammatory response exerts beneficial effects on anger in treatment-resistant bipolar depressionJournal of Affective Disorders Reports 2023; 13: 100602 doi: 10.1016/j.jadr.2023.100602
18
Ashish Verma, Anmol Kumar, Satendra Chauhan, Nisha Sharma, Anuradha Kalani, Prakash Chandra Gupta. Interconnections of screen time with neuroinflammationMolecular and Cellular Biochemistry 2025; 480(3): 1519 doi: 10.1007/s11010-024-05123-9
19
Xenia Gonda, Gianluca Serafini, Peter Dome. Fight the Fire: Association of Cytokine Genomic Markers and Suicidal Behavior May Pave the Way for Future TherapiesJournal of Personalized Medicine 2023; 13(7): 1078 doi: 10.3390/jpm13071078
20
Bárbara Dicarlo Costa Braga, Bruna Teixeira da Costa, Katiene Rodrigues Menezes de Azevedo. Tratamento anti-inflamatório na depressão: uma revisão sistemáticaDebates em Psiquiatria 2024; 14: 1 doi: 10.25118/2763-9037.2024.v14.1156
21
Erhan Kavakbasi, Emma Sampson, Natalie T. Mills, Hikaru Hori, Kathrin Schwarte, Christa Hohoff, K. Oliver Schubert, Scott R. Clark, Célia Fourrier, Bernhard T. Baune. Inflammation‐stratified augmentation of vortioxetine with celecoxib: Results from a double‐blind, randomized, placebo‐controlled trial in major depressive disorderJournal of Neurochemistry 2024; 168(9): 1817 doi: 10.1111/jnc.15946
22
Cheng-gang Li, Lu-shan Xu, Liang Sun, Yu-hao Xu, Xiang Cao, Chen-chen Zhao, Sheng-nan Xia, Qing-xiu Zhang, Yun Xu. Xiangshao Granules Ameliorate Post-stroke Depression by Inhibiting Activation of Microglia and IDO1 Expression in Hippocampus and Prefrontal CortexChinese Journal of Integrative Medicine 2025; 31(1): 28 doi: 10.1007/s11655-024-3903-5
23
Marcel Bertsch-Gout, Anthony T. Reder, Royce Lee. Stress: Immunology and Inflammation2024; : 147 doi: 10.1016/B978-0-12-817558-3.00017-2
24
Bruna R. Kouba, Laura de Araujo Borba, Pedro Borges de Souza, Joana Gil-Mohapel, Ana Lúcia S. Rodrigues. Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological TargetsCells 2024; 13(5): 423 doi: 10.3390/cells13050423
25
Anna Łysik, Katarzyna Logoń, Aleksandra Szczygieł, Julia Wołoszczak, Martyna Wrześniewska, Jerzy Leszek. Innovative approaches in the treatment-resistant depression: exploring different therapeutic pathwaysGeroScience 2025; 47(4): 5543 doi: 10.1007/s11357-025-01615-8